Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Common stock, par value $0.00001 per share · CUSIP: 69353Y103

Event date: 2025-09-30

Filing-level shares
2,636,548.00
Percent of class
4.98%
  • Sio Capital Management, LLC

    Shares: 2,636,548.00 · Class: 4.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-016264
Form type
SCHEDULE 13G/A
Filer
PMV Pharmaceuticals, Inc.
CIK
CIK 1699382
Filed
Nov 12, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub